Sarepta Therapeutics Inc (NASDAQ:SRPT) shares saw strong trading volume on Friday after Cantor Fitzgerald raised their price target on the stock from $175.00 to $211.00. Cantor Fitzgerald currently has an overweight rating on the stock. 10,790,598 shares changed hands during mid-day trading, an increase of 673% from the previous session’s volume of 1,395,266 shares.The stock last traded at $132.05 and had previously closed at $100.47
A number of other equities analysts have also issued reports on the company. Janney Montgomery Scott upped their target price on Sarepta Therapeutics from $160.00 to $175.00 and gave the company a “buy” rating in a research report on Friday. Leerink Swann upped their target price on Sarepta Therapeutics from $186.00 to $216.00 and gave the company an “outperform” rating in a research report on Friday. Guggenheim assumed coverage on Sarepta Therapeutics in a research report on Friday, November 1st. They issued a “buy” rating and a $183.00 target price on the stock. ——-_____________________\\ So this is the space to be in —DMD.. Can’t wait for Monday..$$$$
ANP Price at posting:
8.2¢ Sentiment: Buy Disclosure: Held
